| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $38.8M | +134.9% |
| SG&A Expense | $6.2M | -30.6% |
| Operating Income | -$45.0M | -76.5% |
| Pre-tax Income | -$56.2M | -121.9% |
| Net Income | -$56.2M | -121.9% |
| EPS (Basic) | -$6.23 | -101.0% |
| EPS (Diluted) | -$6.23 | -101.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.8M | -79.7% |
| Current Assets | $10.2M | -71.7% |
| Total Assets | $10.2M | -71.7% |
| Current Liabilities | $4.3M | -44.4% |
| Total Liabilities | $18.0M | +133.3% |
| Stockholders' Equity | -$7.8M | -127.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.0M | -130.9% |
| Financing Cash Flow | $17.3M | — |